Moreover, DPP-4i–driven NRF2/ARE transcriptional activation (Figure 7B) and NRF2-responsive genes were also markedly abrogated by HO-1 inhibition (Figure 7C), indicating that HO-1 may feedback regulate NRF2 activation in DPP-4i–treated BC cells. The gene discussed is HMOX1; the disease is breast cancer.